Mohamed Sfaxi

574 total citations
22 papers, 361 citations indexed

About

Mohamed Sfaxi is a scholar working on Surgery, Molecular Biology and Rheumatology. According to data from OpenAlex, Mohamed Sfaxi has authored 22 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Surgery, 10 papers in Molecular Biology and 7 papers in Rheumatology. Recurrent topics in Mohamed Sfaxi's work include Bladder and Urothelial Cancer Treatments (10 papers), Urinary and Genital Oncology Studies (7 papers) and Epigenetics and DNA Methylation (6 papers). Mohamed Sfaxi is often cited by papers focused on Bladder and Urothelial Cancer Treatments (10 papers), Urinary and Genital Oncology Studies (7 papers) and Epigenetics and DNA Methylation (6 papers). Mohamed Sfaxi collaborates with scholars based in Tunisia, Portugal and France. Mohamed Sfaxi's co-authors include Mohamed Chébil, M Ayed, Raja Marrakchi, Slah Ouerhani, Mohamed Riadh Ben Slama, R Zermani, Amel Benammar Elgaaïed, A. Derouiche, A. Bouzouita and Maria João Prata and has published in prestigious journals such as BMC Cancer, Cancer Investigation and Cancer Genetics and Cytogenetics.

In The Last Decade

Mohamed Sfaxi

21 papers receiving 343 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mohamed Sfaxi Tunisia 10 213 167 106 103 74 22 361
Ahmed Aboumohamed United States 10 220 1.0× 65 0.4× 32 0.3× 113 1.1× 151 2.0× 32 392
Hugh C. Bredin Ireland 10 190 0.9× 78 0.5× 71 0.7× 77 0.7× 54 0.7× 20 287
Dong Hyeon Lee South Korea 9 155 0.7× 81 0.5× 36 0.3× 53 0.5× 52 0.7× 30 273
Bruce A. Kletscher United States 9 171 0.8× 228 1.4× 15 0.1× 140 1.4× 399 5.4× 13 477
A. Thanos Greece 9 102 0.5× 67 0.4× 25 0.2× 67 0.7× 80 1.1× 26 303
Niall Harty United States 7 211 1.0× 132 0.8× 48 0.5× 58 0.6× 140 1.9× 11 373
Yong-zhong Mao China 12 311 1.5× 42 0.3× 64 0.6× 26 0.3× 88 1.2× 21 380
Linguo Xie China 10 126 0.6× 135 0.8× 12 0.1× 30 0.3× 146 2.0× 39 355
J. R. G. BASTABLE United Kingdom 10 191 0.9× 34 0.2× 26 0.2× 109 1.1× 101 1.4× 17 331
Didier Bon France 6 111 0.5× 29 0.2× 78 0.7× 94 0.9× 202 2.7× 7 301

Countries citing papers authored by Mohamed Sfaxi

Since Specialization
Citations

This map shows the geographic impact of Mohamed Sfaxi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohamed Sfaxi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohamed Sfaxi more than expected).

Fields of papers citing papers by Mohamed Sfaxi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohamed Sfaxi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohamed Sfaxi. The network helps show where Mohamed Sfaxi may publish in the future.

Co-authorship network of co-authors of Mohamed Sfaxi

This figure shows the co-authorship network connecting the top 25 collaborators of Mohamed Sfaxi. A scholar is included among the top collaborators of Mohamed Sfaxi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohamed Sfaxi. Mohamed Sfaxi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bouzouita, A., et al.. (2012). Multilocular Cystic Renal Cell Carcinoma. Elsevier eBooks. 87(3). 273–273. 59 indexed citations
2.
Bougatef, Karim, Raja Marrakchi, Nejla Stambouli, et al.. (2011). The effect of tobacco, XPC, ERCC2 and ERCC5 genetic variants in bladder cancer development. BMC Cancer. 11(1). 101–101. 37 indexed citations
3.
Stambouli, Nejla, Raja Marrakchi, Mohamed Riadh Ben Slama, et al.. (2011). Smoking and polymorphisms in folate metabolizing genes and their effects on the histological stage and grade for bladder tumors. Bulletin du Cancer. 98(2). E1–E10. 8 indexed citations
4.
Ouerhani, Slah, Nadia Kourda, Raja Marrakchi, et al.. (2009). Combined Analysis of Smoking, TP53, and FGFR3 Mutations in Tunisian Patients with Invasive and Superficial High-Grade Bladder Tumors. Cancer Investigation. 1–1. 1 indexed citations
5.
Ouerhani, Slah, Nadia Kourda, Raja Marrakchi, et al.. (2009). Combined Analysis of Smoking,TP53, andFGFR3Mutations in Tunisian Patients with Invasive and Superficial High-Grade Bladder Tumors. Cancer Investigation. 27(10). 998–1007. 12 indexed citations
6.
Ouerhani, Slah, Raja Marrakchi, Lotfi Cherni, et al.. (2009). Polymorphisms in one-carbon metabolism pathway genes and risk for bladder cancer in a Tunisian population. Cancer Genetics and Cytogenetics. 195(1). 43–53. 25 indexed citations
7.
Ouerhani, Slah, Raja Marrakchi, Mohamed Riadh Ben Slama, et al.. (2009). Combined effect of NAT2, MTR and MTHFR genotypes and tobacco on bladder cancer susceptibility in Tunisian population. Cancer Detection and Prevention. 32(5-6). 395–402. 14 indexed citations
8.
Ouerhani, Slah, Raja Marrakchi, Mohamed Riadh Ben Slama, et al.. (2009). Combined effect of smoking and inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1 on bladder cancer in a Tunisian population. Cancer Genetics and Cytogenetics. 190(2). 101–107. 27 indexed citations
9.
Sfaxi, Mohamed, et al.. (2008). Réactions systémiques après traitement endovésical par le BCG : à propos de 4 cas. Therapies. 63(1). 43–47. 1 indexed citations
10.
Sfaxi, Mohamed, et al.. (2008). [Reno-colo-pancreatic fistula: an exceptional complication of renal hydatic cyst].. PubMed. 86(9). 840–1. 1 indexed citations
11.
Sfaxi, Mohamed, et al.. (2008). Fracture of the Penis: Management and Long-Term Results of Surgical Treatment. Experience in 300 Cases. The Journal of Trauma: Injury, Infection, and Critical Care. 64(1). 121–125. 70 indexed citations
12.
Ouerhani, Slah, Raja Marrakchi, Mohamed Riadh Ben Slama, et al.. (2008). The role of CYP2D6*4 variant in bladder cancer susceptibility in Tunisian patients.. PubMed. 95(2). E1–4. 13 indexed citations
13.
Ouerhani, Slah, Raja Marrakchi, Mohamed Riadh Ben Slama, et al.. (2007). Methylenetetrahydrofolate reductase and methionine synthase polymorphisms and risk of bladder cancer in a Tunisian population. Cancer Genetics and Cytogenetics. 176(1). 48–53. 26 indexed citations
14.
Sfaxi, Mohamed, et al.. (2007). Clinical Presentation and Outcome of Bladder Schistosoma–Unrelated Squamous Cell Carcinoma: Report on 33 Consecutive Cases. Clinical Genitourinary Cancer. 5(6). 409–412. 3 indexed citations
15.
Zermani, R, et al.. (2007). [Prognostic value of the immunohistochemical expression of: Ki67, p53, PCNA and Bcl2 in the superficial tumors of the bladder].. PubMed. 85(6). 509–12. 1 indexed citations
16.
Ayed, M, et al.. (2006). Prognostic factors of recurrence after vesicovaginal fistula repair. International Journal of Urology. 13(4). 345–349. 42 indexed citations
17.
Sfaxi, Mohamed, et al.. (2006). [Surgical treatment of post-traumatic complete urethral rupture: deferred urgent urethral suture or delayed repair?].. PubMed. 16(4). 464–9. 4 indexed citations
18.
Zermani, R, et al.. (2006). [Prostatic stromal sarcoma].. PubMed. 16(3). 381–3. 6 indexed citations
19.
Kâaroud, H., et al.. (2005). La pyélonéphrite emphysémateuse. Néphrologie & Thérapeutique. 1(4). 247–251. 2 indexed citations
20.
Sfaxi, Mohamed, et al.. (2003). [Treatment of ureteral stones by ESWL. Indications and results in 201 cases].. PubMed. 13(1). 50–3. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ahmed Aboumohamed Breakdown of academic impact, for papers by Hugh C. Bredin Breakdown of academic impact, for papers by Dong Hyeon Lee Breakdown of academic impact, for papers by Bruce A. Kletscher Breakdown of academic impact, for papers by A. Thanos Breakdown of academic impact, for papers by Niall Harty Breakdown of academic impact, for papers by Yong-zhong Mao Breakdown of academic impact, for papers by Linguo Xie Breakdown of academic impact, for papers by J. R. G. BASTABLE Breakdown of academic impact, for papers by Didier Bon
Rankless by CCL
2026